The study also opens the door to new kinds of treatments that do not rely solely on antibiotics. Some of the surviving bacteria are fragile in specific ways, especially in their outer membranes.

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Environmental and chemical exposures have emerged as critical contributors to the global cancer burden. Sources such as dietary contaminants, food ...

Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...

Fresh lava looks like the last place anything could live, yet biologists are now finding microbial communities moving in ...

Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...

A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

New study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes,” not ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...